Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Deviation Management

Posted on By

SOP for Deviation Management

Standard Operating Procedure for Managing Deviations

1) Purpose

The purpose of this SOP is to establish a procedure for the identification, documentation, investigation, and resolution of deviations from established procedures and specifications.

2) Scope

This SOP applies to all personnel involved in the manufacturing, testing, and quality control of pharmaceutical products within the facility.

3) Responsibilities

The responsibilities for this SOP are divided among various roles:

3.1 All Personnel:

Responsible for identifying and reporting deviations.

3.2 Quality Assurance (QA) Personnel:

Responsible for investigating deviations, determining root causes, and implementing corrective and preventive actions (CAPA).

See also  SOP for Validation of Manufacturing Processes

3.3 Department Managers:

Responsible for ensuring deviations are managed in accordance with this SOP.

4) Procedure

4.1 Identification and Reporting of Deviations:

4.1.1 Identify deviations from established procedures and specifications.
4.1.2 Report deviations immediately to the QA department.
4.1.3 Document deviations using the Deviation Report Form.

4.2 Investigation of Deviations:

4.2.1 QA personnel must investigate reported deviations to determine root causes.
4.2.2 Interview relevant personnel and review documentation and records.
4.2.3 Document the findings of the investigation, including the identified root cause.

4.3 Implementation of Corrective and Preventive Actions (CAPA):

4.3.1 Develop CAPA plans to address the root causes of deviations.
4.3.2 Implement CAPA plans promptly to prevent recurrence of deviations.
4.3.3 Monitor the effectiveness of CAPA plans and make adjustments as necessary.

See also  SOP for Good Manufacturing Practices (GMP) Compliance

4.4 Documentation and Review:

4.4.1 Document all steps of the deviation management process, including identification, investigation, and CAPA implementation.
4.4.2 Review deviation records regularly to identify trends and areas for improvement.
4.4.3 Ensure all deviation records are complete, accurate, and stored securely.

5) Abbreviations, if any

QA – Quality Assurance
CAPA – Corrective and Preventive Actions

6) Documents, if any

1. Deviation Report Forms
2. Investigation Records
3. CAPA Plans
4. Deviation Logs

7) Reference, if any

1. FDA Guidance on Good Manufacturing Practices (GMP)
2. ICH Q10 Pharmaceutical

Quality System

8) SOP Version

Version 1.0

Rectal Dosage Forms Tags:Enema preparation guidelines, GMP for rectal products, Rectal administration SOP, Rectal dosage batch record keeping, Rectal dosage change control procedure, Rectal dosage cleaning validation, Rectal dosage emergency response SOP, Rectal dosage environmental monitoring SOP, Rectal dosage facility sanitation SOP, Rectal dosage form stability testing SOP, Rectal dosage forms SOP, Rectal dosage GMP guidelines, Rectal dosage incident investigation procedure, Rectal dosage manufacturing procedures, Rectal dosage raw material handling SOP Rectal dosage equipment maintenance SOP, Rectal dosage risk management plan, Rectal dosage SOP templates, Rectal dosage sterilization SOP, Rectal dosage supplier qualification SOP, Rectal dosage testing procedures, Rectal drug delivery systems SOP, Rectal drug formulation SOP, Rectal enema preparation SOP, Rectal medication packaging SOP, Rectal product contamination control SOP, Rectal product documentation management, Rectal product inspection SOP, Rectal product labeling SOP, Rectal product quality control SOP, Rectal product storage SOP, Rectal suppository manufacturing guidelines, Suppository manufacturing SOP

Post navigation

Previous Post: SOP for Cleaning and Sanitization of Manufacturing Equipment
Next Post: SOP for Angle of Repose Testing in Powders

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version